DASH vs PLRX · P/E 76, rev $13.72B vs $77.3M cap
DoorDash, Inc. Class A Common Stock (DASH) versus Pliant Therapeutics Inc (PLRX) — a side-by-side from cached financials, not a winner call.
DoorDash, Inc. Class A Common Stock (DASH) is a internet retail company listed on US.
Pliant Therapeutics Inc (PLRX) is a biotechnology company listed on US.
Latest reported DASH revenue for 2025-12-31 was $13.72B. Net income was $935.0M. Revenue was up 27.9% from 2024-12-31 to 2025-12-31. DASH currently screens at market cap $69.41B and trailing P/E 75.9.
Latest reported PLRX revenue for 2024-12-31 was $0. Net income was -$210.3M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. PLRX currently screens at market cap $77.3M.
DASH currently screens at market cap $69.41B and trailing P/E 75.9. PLRX currently screens at market cap $77.3M.
Not investment advice. Open the DASH and PLRX stock pages for the full models.
Not investment advice.